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Introduction 
 
The microbiome is a major determinant of colonic health. 
Shifts in the microbiome community (dysbiosis) have 
been reported in IBD but interpretation of dysbiosis is 
fraught by confounding factors that include a large inter-
individual variation due to many factors including the 
genetics of the host glycobiome and mucosal immune 
system, stochastic microbiota founder effects and 
exogenous substrate.  
 
Aim & Methods 
 
To characterise the caecal mucosa-associated microbiome 
of contemporaneous regular chow-fed 5-7 week wild type 
and Muc2 Winnie -/- C57Bl/6 mice inbred mice strains 
derived from the same animal facility and housed in the 
same cages for each test condition : vehicle gavage, daily 6-
thioguanine (6TG) gavage 0.2-0.5 mg/kg over 14 days. DNA 
was extracted from faeces (F) at D0 and D14 and caecal 
mucosa (CM) and contents (CC) at D14. The resident 
microbiota in the samples was analysed employing a bar-
coded pyrosequencing approach targeting Bacterial 16S 
rRNA genes. 
 
Results 
 
The faecal microbiome was not stable over time in juvenile 
mice given vehicle only. 6TG altered the CM microbiome in 
wild type C57Bl/6 mice towards less Bacteroidetes and 
increased Firmicutes (mainly Lachnospiraceae, and 
Erysipelotrichaceae) (Figures 1 and 2). 6TG did not 
significantly alter the Muc2 Winnie -/- CM microbiome, which 
had a reduced proportion of Firmicutes and an increased 
proportion of all Bacteroidetes groups. 
 
Figure 2: Based on the results derived 
from the dpcoa exploring variation 
across the CM samples from wild type 
C57Bl/6  mice (Figure 1), relative 
abundances of chosen phylogenetic 
groups across these samples were 
recovered. Observed differences 
between the samples originating from 
the control and 6TG treatments were 
further analyzed using a statistical test 
(wilcoxon test, a=0.05, FDR). The 
results are concordant with the dpcoa 
and show that treatment with 6TG 
produced a significant (*) decrease in 
the relative abundance of members of 
the Bacteroidetes with a concomitant 
significant increase in the proportion of 
Firmicutes related sequences and more 
specifically in sequences related to the 
Erysipelotrichaceae family.  
Figure 1: Double principal coordinate analysis (dpcoa) based on the bacterial community 
profiles of the CM samples from the C57Bl/6 mice. In this case, the dpcoa performed aimed to 
ordinate the samples based on the taxonomic relationships (phylogenetic distance) and 
abundance of the bacterial species (OTUs at 0.97 distance) present in their resident 
microbiota. Each ellipsoid represents the collective variance of each treatment (Blue; control. 
Red; 6TG). The position of each point represent the association of each OTU with each 
sample. Points are coloured and collectively labelled based on their taxonomy (obtained from 
the Ribosomal Database Project algorithm, rank level chosen to facilitate visualization). The 
analysis indicates a strong partitioning of the samples based on treatment type driven by the 
relative abundances of Bacteroidetes (but possibly not Rikenellaceae and Prevotellaceae 
within this clade) and several groups within the Firmicutes. A subsequent between-group 
analysis coupled with a Montecarlo permutation test confirmed that treatment type had a 
significant effect on the microbiota profiles (p < 0.02), and explained 34% of the total variance 
in the dataset. 
Conclusion 
 
There is large variation in the caecal mucosal and faecal 
microbiomes even in inbred strains of contemporaneous 
juvenile C57Bl/6 mice littermates. 6TG failed to shift the 
microbiome of Muc2 Winnie -/- suggesting that the epithelial 
defect is more important in determining the dysbiosis. 6TG 
shifted the caecal mucosal microbiome in wildtype mice. A 
recent high throughput sequence analysis of the mucosal 
microbiome of IBD patients has shown “Firmicutes were 
reduced in IBD samples and there were concurrent increases 
in Bacteroidetes”*. This together with our study of a thiopurine 
effect on the CM microbiome of inbred mice in a controlled 
environment, suggests that 6TG–antibioisis may contribute to 
Rx efficacy. 
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